NAGE 250516 6.00C(NAGE250516C6000) Stock Price Today | Quotes & News - Moomoo

US OptionsDetailed Quotes

NAGE250516C6000

Watchlist

2.00
+0.05+2.56%

15min DelayClose May 2 15:59 ET

2.00High2.00Low

Intraday

5D
Daily

News

Earnings Preview: NAGE to Report Financial Results Post-market on May 07
Moomoo NewsMay 1 21:00 ET
Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board
BusinesswireApr 29 08:32 ET
Express News | Niagen Bioscience Welcomes DR. Pinchas Cohen to Scientific Advisory Board
ReutersApr 29 08:32 ET
Press Release: Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
Dow JonesApr 28 08:36 ET
Roth MKM Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $8
Moomoo NewsApr 8 03:33 ET · Ratings
Sector Update: Health Care Stocks Slipping in Afternoon Trading
MT NewswiresApr 7 14:05 ET

Comments

$ChromaDex (CDXC.US)$
this is $Niagen Bioscience (NAGE.US)$ now

Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms

$Niagen Bioscience (NAGE.US)$
Game-Changing Patent Win: Niagen Locks Down Exclusive Rights to Critical NR Technology

Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms

$Niagen Bioscience (NAGE.US)$ Niagen Bioscience Secures US Patent For Composition Of Matter For Nicotinamide Riboside Salt Forms
Benzinga· 2mins ago

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science

$Niagen Bioscience (NAGE.US)$
ChromaDex Transforms to Niagen Bioscience as NAD+ Leader Reports Record $99.6M Revenue

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science

Read more